072020 — Choong Ang Vaccine Laboratory Co Balance Sheet
0.000.00%
- KR₩83bn
- KR₩66bn
- KR₩49bn
Annual balance sheet for Choong Ang Vaccine Laboratory Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 21,468 | 17,987 | 27,424 | 29,153 | 24,238 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,442 | 3,401 | 4,502 | 5,183 | 4,765 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 39,844 | 39,590 | 50,561 | 52,450 | 51,610 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 66,091 | 66,969 | 63,272 | 64,421 | 63,877 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 112,952 | 114,859 | 119,593 | 123,275 | 122,816 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14,361 | 13,313 | 12,653 | 12,012 | 12,094 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 19,976 | 19,554 | 19,788 | 19,408 | 17,447 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 92,976 | 95,304 | 99,804 | 103,867 | 105,369 |
| Total Liabilities & Shareholders' Equity | 112,952 | 114,859 | 119,593 | 123,275 | 122,816 |
| Total Common Shares Outstanding |